Réactifs et instruments pour l'immunologie, la biologie cellulaire et la biologie moléculaire.
 
> BMS-986313 is a potent, selective, orally active RORγt inverse agonist with EC50 of 3.6 nM in GAL-4 reporter assay in Jurkat cell line, and 50 nM in IL-17 human whole blood assay.BMS-986313 demonstrated robust efficacy in preclinical models of psoriasis (the IMQ-induced skin lesion model and the IL-23-induced acanthosis model).

BMS-986313 is a potent, selective, orally active RORγt inverse agonist with EC50 of 3.6 nM in GAL-4 reporter assay in Jurkat cell line, and 50 nM in IL-17 human whole blood assay.BMS-986313 demonstrated robust efficacy in preclinical models of psoriasis (the IMQ-induced skin lesion model and the IL-23-induced acanthosis model).

Imprimer Imprimer
Identifiez-vous

Référence orb1910405-1g

Conditionnement : 1g

Marque : Biorbyt

Contactez votre distributeur local :


Téléphone : +1 850 650 7790